TT Capital Partners, NovaQuest Capital Management, and Frist Cressey Ventures Invests in InformedDNA

We represented TT Capital Partners (TTCP), NovaQuest Capital Management (NovaQuest) and Frist Cressey Ventures in its recapitalization and growth equity investment in InformedDNA, the nation’s largest provider of genetic services. InformedDNA will use the capital to continue scaling its technology-enabled, genetics expert services, as well as to expand its staff of genetic counselors. Terms of the transaction were not disclosed.

The TTCP and NovaQuest Capital Management deal teams were led by Ryan Thomas and included corporate attorneys Ryan Hoffman, Bo Cook, Gardner Bell and Oliver Peglow. Philip Lewis counseled on tax issues while Shannon Wiley and Whitney Snow advised on healthcare regulatory issues; Felix Dowsley and Vincent Lillegard advised on financing-related matters; Shelley Thomas, Emily Burrows and Stefanie Colletier advised on intellectual property matters; and Kimberly Veirs advised on labor and employment matters. Michael Holley also advised Frist Cressey Ventures in its minority investment.

You Also May Be Interested In:

  • Representation of AutoZone, Inc. (NYSE: AZO) in a public offering of $500,000,000 of 3.625% Senior Notes due 2025 and $750,000,000 of 4.000% Senior Notes due 2030

    We represented AutoZone, Inc. in a public offering of $500,000,000 of 3.625% Senior Notes due 2025 and $750,000,000 of 4.000%...
    Client Type: Public Company
  • We represented Pharos Capital’s post-acute care provider platform, Charter Health Care Group, in its acquisition of two hospice service providers,...
    Client Type: Private Company
  • Representation of axialHealthcare, a care optimization platform navigating substance use issues for patients, providers, and health plans, in a $15 million Series C round of financing to accelerate its expansion into the substance use disorder (SUD) treatment, and recovery sector. Previous institutional investors Oak HC/FT, .406 Ventures, BlueCross BlueShield Venture Partners (BCBSVP), and Sandbox Advantage Fund led the round.

    We represented axialHealthcare, a care optimization platform navigating substance use issues for patients, providers, and health plans, in a $15...
    Client Type: Private Company